Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Haynes

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Inflammatory Bowel Diseases|April 12, 2023
Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare DatabasesGhadeer K Dawwas, Alexandra Weiss, Brad D Constant, et al.
BMC Pharmacology & Toxicology|April 19, 2015
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugsM Elle Saine, Dena M Carbonari, Craig W Newcomb, et al.
Inflammatory Bowel Diseases|June 26, 2023
Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative ColitisSruthi Adimadhyam, James D Lewis, Andrew L Simon, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2015
Validity of diagnostic codes and laboratory tests of liver dysfunction to identify acute liver failure eventsVincent Lo Re, Dena M Carbonari, Kimberly A Forde, et al.
Gastroenterology|July 22, 2023
Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United StatesJames D Lewis, Lauren E Parlett, Michele L Jonsson Funk, et al.
Gastroenterology|March 4, 2015
Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care systemDavid S Goldberg, Kimberly A Forde, Dean M Carbonari, et al.
Crohn'S & Colitis 360|June 23, 2023
Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus TofacitinibMichael D Kappelman, Millie D Long, Xian Zhang, et al.
Circulation. Cardiovascular Quality and Outcomes|May 30, 2020
Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLEFaraz S Ahmad, Iben M Ricket, Bradley G Hammill, et al.
American Heart Journal|September 19, 2020
Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib)Sana M Al-Khatib, Sean D Pokorney, Hussein R Al-Khalidi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2015
Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic ModelVincent Lo Re, Kevin Haynes, Kimberly A Forde, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Inflammatory Bowel Diseases|April 12, 2023
Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare DatabasesGhadeer K Dawwas, Alexandra Weiss, Brad D Constant, et al.
BMC Pharmacology & Toxicology|April 19, 2015
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugsM Elle Saine, Dena M Carbonari, Craig W Newcomb, et al.
Inflammatory Bowel Diseases|June 26, 2023
Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative ColitisSruthi Adimadhyam, James D Lewis, Andrew L Simon, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2015
Validity of diagnostic codes and laboratory tests of liver dysfunction to identify acute liver failure eventsVincent Lo Re, Dena M Carbonari, Kimberly A Forde, et al.
Gastroenterology|July 22, 2023
Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United StatesJames D Lewis, Lauren E Parlett, Michele L Jonsson Funk, et al.
Gastroenterology|March 4, 2015
Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care systemDavid S Goldberg, Kimberly A Forde, Dean M Carbonari, et al.
Crohn'S & Colitis 360|June 23, 2023
Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus TofacitinibMichael D Kappelman, Millie D Long, Xian Zhang, et al.
Circulation. Cardiovascular Quality and Outcomes|May 30, 2020
Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLEFaraz S Ahmad, Iben M Ricket, Bradley G Hammill, et al.
American Heart Journal|September 19, 2020
Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib)Sana M Al-Khatib, Sean D Pokorney, Hussein R Al-Khalidi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2015
Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic ModelVincent Lo Re, Kevin Haynes, Kimberly A Forde, et al.
Pageof 17